Blueprint Medicines Operating Income 2014-2024 | BPMC
- Blueprint Medicines annual operating income for 2023 was $-0.486B, a 9.53% decline from 2022.
- Blueprint Medicines annual operating income for 2022 was $-0.538B, a 16.27% decline from 2021.
- Blueprint Medicines annual operating income for 2021 was $-0.642B, a 307.96% decline from 2020.